Benefit of salvage total pharyngolaryngoesophagectomy for recurrent locally advanced head and neck cancer after radiotherapy

被引:9
作者
Liu, Jie [1 ]
Zhang, Ye [2 ]
Li, Zhengjiang [1 ]
Liu, Shaoyan [1 ]
Li, Huizheng [3 ]
Xu, Zhengang [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Dept Head & Neck Surg Oncol, Natl Canc Ctr,Canc Hosp, 17 Panjiayuan Nanli,Head & Neck Ward 1, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Dept Radiat Oncol, Natl Canc Ctr,Canc Hosp, Beijing, Peoples R China
[3] Dalian Friendship Hosp, Dept Otorhinolaryngol, Dalian, Peoples R China
来源
RADIATION ONCOLOGY | 2017年 / 12卷
关键词
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; RANDOMIZED-TRIALS; LARYNGEAL-CANCER; SURGERY; THERAPY; FAILURE; CHEMORADIATION;
D O I
10.1186/s13014-017-0900-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The treatment modalities for recurrent locally advanced head and neck cancer failure after radiotherapy are limited with poor prognosis. Salvage supra-radical operation seems to be an option. It has not been established which patients will benefit from salvage total pharyngolaryngoesophagectomy. Methods: We retrospectively reviewed 66 patients with previously irradiated recurrent T4 head and neck cancer who underwent salvage total pharyngolaryngoesophagectomy at our institution between January 2001 and June 2014. The clinical outcome and toxicities were analyzed. Results: Flap loss occurred in 2 patients, and the incidence of fistulas and anastomosis strictures was 15.6% (10/66) and 13.6% (9/66), respectively. The median survival time of the entire cohort was 12 months. The interval between radiation and salvage surgery, and microscopic carotid artery invasion were identified as independent prognostic factors for overall survival. The 3-year overall survival rates of patients with (n = 33) and without (n = 33) risk factors were 9.1% and 47.2%, respectively (p = 0.007). A time interval between radiation and salvage surgery <= 6 months and previous concurrent chemotherapy or targeted therapy were risk factors for severe post-operative complications. Conclusions: Salvage total pharyngolaryngoesophagectomy is beneficial to selected patients with recurrent locally advanced head and neck cancer after radiotherapy.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
    Magrini, Stefano Maria
    Buglione, Michela
    Corvo, Renzo
    Pirtoli, Luigi
    Paiar, Fabiola
    Ponticelli, Pietro
    Petrucci, Alessia
    Bacigalupo, Almalina
    Crociani, Monica
    Lastrucci, Luciana
    Vecchio, Stefania
    Bonomo, Pierluigi
    Pasinetti, Nadia
    Triggiani, Luca
    Cavagnini, Roberta
    Costa, Loredana
    Tonoli, Sandro
    Maddalo, Marta
    Grisanti, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (05) : 427 - +
  • [22] Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
    L. López
    P. García-Cabo
    J. L. Llorente
    F. López
    J. P. Rodrigo
    European Archives of Oto-Rhino-Laryngology, 2024, 281 : 945 - 951
  • [23] Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity
    Acevedo-Henao, C. M.
    Valette, G.
    Miglierini, P.
    Lefur, E.
    Pradier, O.
    CANCER RADIOTHERAPIE, 2012, 16 (07): : 601 - 603
  • [24] Salvage surgery in head and neck cancer
    van Weert, Stijn
    Leemans, C. Rene
    ORAL DISEASES, 2021, 27 (01) : 117 - 124
  • [25] Hypothyroidism after radiotherapy of head and neck cancer
    Bernat, Ladislav
    Hrusak, Daniel
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2014, 42 (04) : 356 - 361
  • [26] Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma
    Fushimi, Chihiro
    Okamoto, Isaku
    Matsuki, Takashi
    Masubuchi, Tatsuo
    Okada, Takuro
    Sato, Hiroki
    Tsukahara, Kiyoaki
    Kondo, Takahito
    Yamashita, Taku
    Hanyu, Kenji
    Omura, Go
    Takahashi, Hideaki
    Tada, Yuichiro
    Miura, Kouki
    ANTICANCER RESEARCH, 2020, 40 (09) : 5277 - 5283
  • [27] Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan
    Yasuda, Koichi
    Uchinami, Yusuke
    Kano, Satoshi
    Taguchi, Jun
    Kawakita, Daisuke
    Kitayama, Megumi
    Nishioka, Kentaro
    Mori, Takashi
    Koizumi, Fuki
    Fujii, Yuri
    Shimizu, Yasushi
    Kobashi, Keiji
    Yoshimoto, Seiichi
    Nibu, Ken-ichi
    Homma, Akihiro
    Aoyama, Hidefumi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (03) : 241 - 247
  • [28] Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy
    Abreu, Andre Luis de Castro
    Bahn, Duke
    Leslie, Scott
    Shoji, Sunao
    Silverman, Paul
    Desai, Mihir M.
    Gill, Inderbir S.
    Ukimura, Osamu
    BJU INTERNATIONAL, 2013, 112 (03) : 298 - 307
  • [29] Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer
    Ferris, Robert L.
    Moskovitz, Jessica
    Kunning, Sheryl
    Ruffin, Ayana T.
    Reeder, Carly
    Ohr, James
    Gooding, William E.
    Kim, Seungwon
    Karlovits, Brian J.
    Vignali, Dario A. A.
    Duvvuri, Umamaheswar
    Johnson, Jonas T.
    Petro, Daniel
    Heron, Dwight E.
    Clump, David A.
    Bruno, Tullia C.
    Bauman, Julie E.
    CLINICAL CANCER RESEARCH, 2022, 28 (07) : 1335 - 1344
  • [30] Concomitant Weekly Cisplatin and Altered Fractionation Radiotherapy in Locally Advanced Head and Neck Cancer
    Newlin, Heather E.
    Amdur, Robert J.
    Riggs, Charles E.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    CANCER, 2010, 116 (19) : 4533 - 4540